Christopher Rovaldi

Geen lopende functies

52 jaar

Health Technology

Commercial Services

Consumer Services

Profiel

Christopher Rovaldi is SVP-Program Management & Operations bij Acceleron Pharma, Inc. De heer Rovaldi was eerder Director-Project Management bij Idenix Pharmaceuticals LLC, Senior Research Associate bij Periodontix, Inc. en Director-Project Management bij Cubist Pharmaceuticals LLC. Hij is afgestudeerd aan de University of New Hampshire en heeft daar ook een bachelor-diploma behaald.

Eerdere bekende functies van Christopher Rovaldi

Bedrijven	Functie	Einde
KEROS THERAPEUTICS, INC.	President	18-08-2025
ACCELERON PHARMA INC.	Operationeel Directeur	01-05-2018
IDENIX PHARMACEUTICALS INC	Corporate Officer/Principal	01-01-2007
CUBIST PHARMACEUTICALS INC	Corporate Officer/Principal	01-01-2004
Periodontix, Inc. Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease	Corporate Officer/Principal	-

Ervaring van Christopher Rovaldi in detail bekijken

Opleiding van Christopher Rovaldi

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Christopher Rovaldi in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	6
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products	Health Technology
Idenix Pharmaceuticals LLC Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis	Health Technology
Acceleron Pharma, Inc. Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases	Health Technology
Periodontix, Inc. Periodontix, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development in the biopharmaceutical industry; develops next generation antimicrobial agents for the prevention and treatment of each stage of periodontal disease	Commercial Services
University of New Hampshire University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Keros Therapeutics, Inc. Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases	Health Technology